Literature DB >> 8393241

A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus.

C F Boerkoel1, M J Federspiel, D W Salter, W Payne, L B Crittenden, H J Kung, S H Hughes.   

Abstract

We have constructed a helper cell line and vector system based on the Bryan high titer (BH) strain of Rous sarcoma virus (RSV). BH-RSV is a defective virus which lacks an env gene; however, if env is supplied in trans, it replicates to a very high titer. Like BH-RSV, the vector contains gag and pol genes and lacks an env gene. The helper cell line supplies env in trans and permits the production of infectious virions. To construct the helper cell line the subgroup A env gene from the Schmidt-Ruppin-A (SRA) RSV was stably transfected into Qt6 cells, a chemically transformed quail fibroblast line. To minimize homology between the vector and helper cell line, transcription of the env gene is driven by a MuLV LTR, and 3' processing is controlled by the simian virus 40 (SV40) polyadenylation signal. This combination of vector and helper cells can be used to produce high-titer viral stocks in which recombinant replication-competent virus have not been detected even when the stocks were used to inoculate chickens. This system should be useful for developing transgenic chickens, studying cell lineage, and introducing genes into cultured cells.

Entities:  

Mesh:

Year:  1993        PMID: 8393241     DOI: 10.1006/viro.1993.1418

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Vectors derived from avian leukosis and sarcoma viruses.

Authors:  F Flamant; F L Cosset; J Samarut
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

2.  Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system.

Authors:  Alexander von Werder; Barbara Seidler; Roland M Schmid; Günter Schneider; Dieter Saur
Journal:  Nat Protoc       Date:  2012-05-24       Impact factor: 13.491

3.  Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors.

Authors:  M J Federspiel; D A Swing; B Eagleson; S W Reid; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

4.  Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.

Authors:  E V Barsov; S H Hughes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection.

Authors:  Jason G Smith; Walther Mothes; Stephen C Blacklow; James M Cunningham
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors.

Authors:  M J Federspiel; P Bates; J A Young; H E Varmus; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 7.  Rediscovering the chick embryo as a model to study retinal development.

Authors:  M Natalia Vergara; M Valeria Canto-Soler
Journal:  Neural Dev       Date:  2012-06-27       Impact factor: 3.842

Review 8.  Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.

Authors:  Andrea J McKinney; Sheri L Holmen
Journal:  Chin J Cancer       Date:  2011-03

9.  IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment.

Authors:  Patricia D B Tiburcio; Bing Xiao; Yi Chai; Sydney Asper; Sheryl R Tripp; David L Gillespie; Randy L Jensen; L Eric Huang
Journal:  Oncotarget       Date:  2018-10-12

10.  Development of retroviral vectors for tissue-restricted expression in chicken embryonic gonads.

Authors:  Luke S Lambeth; Thomas Ohnesorg; David M Cummins; Andrew H Sinclair; Craig A Smith
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.